JLM supports the Pharmaceutical & Diagnostic market JLM with a number of new technologies: anti-counterfeiting for packaging, automation, clinical trials using RFID, biomarkers, micro-fluidic, drug delivery devices, lab on chip and bio chips array with sensors. Typically we work with senior directors of packaging, manufacturing, companion diagnostics, research and development, marketing and global sourcing. Headquartered in St. Davids, PA, JLM is located within two hours of 80 percent of the major pharmaceutical companies.


MBST_Logo_blau_NEU.png
 

MEDTEC MEDIZINTECHNIK GMBH

Sportparkstr. 935578 Wetzlar | Germany Online   www.mbst.de  

Technology: Electronic Medicine A rejuvenate damage cells tissue that can be corrected back to normal with right frequency

Markets: Primary area covered arthritis, osteoporosis, orthopaedic, dermatology (hair growth & skin rejuvenation) and potential with urology (ED erectile dysfunction), improvement in eye-vision and hearing lost. 

 Electronic medicine, in simple terms the body’s cells react to different frequencies and damage cells can be corrected with thee right frequencies. The right frequency is the electronic medicine which is controlled by chip card that is  programmed with right  the “formula.”  The technology works for the same reason as the MRI technology works. The image giving technology is called MRI and we call our technology MRT (T for Therapy). In both technologies the resonance phenomenon is used. Below is file “Technology active principle” to see what is common and what is different subject the MRI and MRT technology.The patented MBST®- therapy from Germany provides body cells (in humans and animals) with new energy through highly specified treatment devices that aim at the particular damaged tissue. Thereby, cell metabolism is reactivated and regeneration is stimulated. Hence, pain will be significantly reduced on a long term basis and mobility will be regained. This treatment is proven out successfully with over 260,000 patients within the last 16 years


UNIVERSAL BIOPHYSICAL STIMULATION MACHINE ALTERNATIVE TO PHARMA AND TARGETS MORE FOR THE CURE THAN CONTINUOUS TREATMENTS. 

gI_88519_Magnesphere.png

Biophysical stimulation is disruptive and needs an outsider in healthcare. Most of the technology is developed out of Germany which is world leader regeneration medicine / digital therapeutics.  The global digital therapeutics market is expected to reach USD 9.3 billion by 2025.  ( "Digital Therapeutics Market 2014 - 2025" report) Digital therapeutics, known as software-as-a-drug, has undergone significant developments, because of its cost-effectiveness and the potential to influence human behaviour - a challenge that is difficult to overcome in healthcare. Our bodies own energy can cure itself by electronic stimulation mainly just need the right frequency. the software replaces a drug. 


prior Companies under JLM:

BALDA MEDICAL, GMBH 

Bergkirchener Str. 22832549 Bad Oeynhausen  Germany    www.balda.de     

Technology: Custom drug delivery devices

Market: Pharmaceutical & BioTechnology OEMs 

Balda Medical is an OEM for custom drug delivery devices with a special niche relating to pill dispensing. Balda creates custom devices for injectable or oral delivery that provide better compliance, safety and special benefits.     

case study


Randox Laboratories Limited

Northern Ireland (one of world's largest producers of biomarkers)

overview

overview